Chronic pulmonary diseases encompass different persistent and lethal diseases, including
chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF), cystic …

Chronic obstructive pulmonary disease patient care must include confirming a diagnosis
with postbronchodilator spirometry. Because of the clinical heterogeneity and the reality that …

The Global Initiative for Chronic Obstructive Lung Disease (GOLD) has published the
complete 2023 GOLD report, which can be freely downloaded from its web page (www …

Abstract The Spanish COPD Guidelines (GesEPOC) were first published in 2012, and since
then have undergone a series of updates incorporating new evidence on the diagnosis and …

Resumen La Guía Española de la Enfermedad Pulmonar Obstructiva Crónica (GesEPOC)
se publicó por primera vez en 2012 y desde entonces ha experimentado una serie de …

The Global Initiative for Chronic Obstructive Lung Disease (GOLD) has issued its 2023
annual report 1. Compared with former versions, it has been significantly updated. Here, we …

The Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2021 report dawns with
an update to the diagnostic, preventive and therapeutic strategies for Chronic obstructive …

Many patients seen by cardiologists suffer chronic obstructive pulmonary disease (COPD) in
addition to their primary cardiovascular problem. Yet, quite often COPD has not been …

Pharmacological treatment for chronic obstructive pulmonary disease (COPD) aims to
alleviate symptoms and reduce the future risk of events such as exacerbations, disease …

Introduction Accumulated high-quality data from randomised controlled trials (RCTs)
indicate that long-acting muscarinic antagonist (LAMA)/long-acting β2 agonist (LABA) …